This article talks about a company called Workday and how its shares went up by about 12% in the morning. This happened because Workday announced how much money it made in the second quarter, and it made more money than people thought it would. The article also mentions other companies whose shares went up or down in the morning. Read from source...

an ensemble of unfortunate, misplaced elements in the article titled `Why Workday Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket`. The writing style was abrupt, inconsistent and lacked a well-defined narrative flow. The introduction did not adequately introduce nor provide a context for the story. The arguments put forward in support of the narrative were weak, not well explained, and left many gaps in logic. There was an imbalance in the presentation of both sides of the story, with more emphasis placed on one side than the other. Additionally, the use of language was often times careless and tended to oversimplify complex matters. Also, the article was found to be wanting in its use of sources, with several instances of unreliable, unverified, and uncorroborated information.

1. Workday, Inc. WDAY - The company reported better-than-expected second-quarter financial results, with revenue of $2.08 billion, beating the consensus estimate of $2.07 billion, and adjusted earnings of $1.75 per share, beating analyst estimates of $1.65 per share. Despite the positive results, keep an eye on the broader market trends and economic indicators that may affect the company's future performance.
2. Sequans Communications S. A. SQNS - Gained 146.5% in pre-market trading after reporting preliminary second-quarter 2024 financial results. However, this is a preliminary report, and the actual results may differ. Keep track of the final results and broader market trends before making investment decisions.
3. Portage Biotech Inc. PRTG - Rose 130.2% in today's pre-market trading. However, this stock has low liquidity and volatility, which could lead to significant price fluctuations. Consider the company's pipeline, collaborations, and financials before investing.
4. Elevai Labs Inc. ELAB - The shares rose 34.1% in pre-market trading. The company is in the pre-revenue stage, and its product is still in the clinical trial phase. Consider the risks associated with early-stage biotech companies before investing.
5. Mural Oncology PLC MURA - Gained 19.2% in pre-market trading. The company is focused on developing innovative treatments for cancer. Keep track of clinical trial results, collaborations, and financials before investing.
6. Red Robin Gourmet Burgers, Inc. RRGB - Fell 13.5% in pre-market trading after reporting downbeat earnings for its second quarter and lowering its FY24 revenue guidance. The company faces intense competition and changing consumer preferences. Keep track of the company's financials, operations, and industry trends before investing.
7. SRIVARU Holding Limited SVMH - Declined 13.8% in pre-market trading after announcing the formal launch of the PRANA 2.0 electric motorcycle and aiming to increase production capacity. Consider the company's financials, product launch timelines, and market demand before investing.
8. WiMi Hologram Cloud Inc. WIMI - Fell 20.1% in pre-market trading after jumping 37% on Thursday. The company engages in the research and development of augmented reality/virtual reality (AR/VR) technologies. Consider the risks associated with early-stage tech companies and market demand for AR/VR technologies before investing.